Tudor Investment Corp
ONC

Tudor Investment Corp’s BeOne Medicines Ltd ONC Stock Holding History

Tudor Investment Corp’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,075
Closed -$565K – 3872
2025
Q1 		$565K Buy
+2,075
New +$485K ﹤0.01% 2206
2023
Q4 		– Sell
-1,600
Closed -$288K – 2990
2023
Q3 		$288K Buy
+1,600
New +$317K ﹤0.01% 1945
2022
Q4 		– Sell
-2,400
Closed -$324K – 2931
2022
Q3 		$324K Buy
2,400
+782
+48% +$134K 0.01% 1740
2022
Q2 		$262K Buy
+1,618
New +$253K 0.01% 1653
2020
Q1 		– Sell
-1,283
Closed -$213K – 1381
2019
Q4 		$213K Buy
+1,283
New +$213K 0.01% 974

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Tudor Investment Corp's ONC Position: Q2 2025 in Review

Tudor Investment Corp sold out of BeOne Medicines Ltd (ONC) in Q2 2025, closing a stake of 2,075 shares — an estimated $565K sold.

Tudor Investment Corp first reported a position in ONC in Q4 2019 and held it in 5 quarters. The position peaked at $565K in Q1 2025. 243 funds tracked by Wall St. Rank hold ONC as of Q2 2025.

  • Tudor Investment Corp reported no remaining BeOne Medicines Ltd position as of Q2 2025 after selling out during the quarter.
  • Tudor Investment Corp sold 2,075 BeOne Medicines Ltd shares in Q2 2025, an estimated $565K.
  • Tudor Investment Corp first reported a position in BeOne Medicines Ltd in Q4 2019 and held it in 5 quarters.
  • Tudor Investment Corp's BeOne Medicines Ltd position peaked at $565K in Q1 2025.
  • 243 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2025.

Based on Tudor Investment Corp's 13F filing for Q2 2025, filed 14 Aug 2025.